17.87
+0.56(+3.24%)
Currency In USD
| Previous Close | 17.31 |
| Open | 17.9 |
| Day High | 18.44 |
| Day Low | 17.52 |
| 52-Week High | 42.47 |
| 52-Week Low | 16.1 |
| Volume | 2.79M |
| Average Volume | 2.57M |
| Market Cap | 2.25B |
| PE | -9.93 |
| EPS | -1.8 |
| Moving Average 50 Days | 18.13 |
| Moving Average 200 Days | 26.01 |
| Change | 0.56 |
If you invested $1000 in Apellis Pharmaceuticals, Inc. (APLS) since IPO date, it would be worth $1,273.7 as of July 02, 2025 at a share price of $17.87. Whereas If you bought $1000 worth of Apellis Pharmaceuticals, Inc. (APLS) shares 5 years ago, it would be worth $542.17 as of July 02, 2025 at a share price of $17.87.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Apellis to Receive up to $300 Million from Royalty Purchase Agreement with Sobi for Ex-U.S. Royalties of Aspaveli® (systemic pegcetacoplan)
GlobeNewswire Inc.
Yesterday at 11:00 AM GMT
Apellis to receive $275 million upfront and up to $25 million in milestone payments upon EMA approval in C3G and IC-MPGNNon-dilutive financing further strengthens Apellis’ balance sheet Apellis retains full U.S. commercialization rights for systemic
Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
GlobeNewswire Inc.
Jun 06, 2025 1:15 PM GMT
Robust proteinuria reduction and stable kidney function were maintained across a broad population of patients No new safety signals were observedNew data presented at late-breaking session at the European Renal Association CongressMarketing applicati
Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire Inc.
Jun 04, 2025 11:00 AM GMT
WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11, 2025 at 10:40 a.m. ET.